Earnings Summary

Ac Immune Sa’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2023. On a quarterly growth basis, Ac Immune Sa has generated NaN% jump in its revenue since last 3-months.

Ac Immune Sa’s net profit jumped 14.31% since last year same period to $-16.83Mn in the Q2 2023. On a quarterly growth basis, Ac Immune Sa has generated 3.88% jump in its net profits since last 3-months.

Ac Immune Sa’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2023. On a quarterly growth basis, Ac Immune Sa has generated NaN% jump in its net profit margins since last 3-months.

Ac Immune Sa’s earning per share (EPS) estimates for the current quarter stand at -0.24 - a 4% jump from last quarter’s estimates.

Ac Immune Sa’s earning per share (EPS) estimates for the current year stand at -0.24.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Ac Immune Sa’s return on assets (ROA) stands at -0.22.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Ac Immune Sa’s return on equity (ROE) stands at -0.39.